Intellicheck, Inc. engages in the development, integration, and marketing of threat and identity authentication solutions. It offers professional services, retail, age, defense, guest, and port ID. The company was founded in 1994 and is headquartered in Melville, NY.

Peraso, Inc. engages in the development and sale of semiconductor devices and modules based on its proprietary semiconductor devices and performance of non-recurring engineering, services and licensing of intellectual property. It operates through the following geographical segments: North America, Hong Kong, Taiwan, and Rest of World. The company was founded in 1991 and is headquartered in San Jose, CA.

Arm Holdings Plc operates as a holding company with interests in providing semiconductor technology. It architects, develops and licenses CPU products and related technology through its subsidiaries. The company was founded in 1990 and is headquartered in Cambridge, the United Kingdom.

PodcastOne, Inc. engages in the operation of a podcasting distribution platform. It is involved in producing vodcasts (video podcasts), branded podcasts, merchandise, and live events on behalf of talent and clients. The company was founded by Norman Joel Pattiz and Kit Gray in October 2012 and is headquartered in Beverly Hills, CA.

LegalZoom.com, Inc. engages in the provision of online legal solutions and services. Its products and services include attorney advice, wills, trusts, and family, and business. The company was founded by Brian P. Y. Liu, Brian S. Lee, Edward R. Hartman, and Robert Leslie Shapiro in July 1999 and is headquartered in Glendale, CA.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.